BioSpace News Archive

Protagen AG, the National Center for Tumor Diseases (NCT) and NEC Laboratories Europe GmbH have today announced a collaboration to improve the in silico prediction of immunotherapy response in malignant melanoma.

Company’s OmniVerita Designed to Enable Early Detection and Monitoring of Cancer

New research marks the latest example of neurofilament light chain (NfL) as a critical biomarker for detecting brain injuries

COPIKTRA is a Dual Inhibitor Approved for Treatment of Adult Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and Relapsed or Refractory Follicular Lymphoma

Phillips-Medisize, a Molex company, an end-to-end provider of innovation, development and manufacturing solutions to the pharmaceutical, diagnostics and medical device industries announces enhanced capabilities which provide for compelling and unique ways of partnering with customers.

Two new scientific published articles in the peer-reviewed magazine of the International Headache Society, confirm the basic mechanism of the Cefaly® device and detail its effect on the nervous system for the treatment of migraine.

PDL BioPharma, Inc., (“PDL” or the “Company”) (NASDAQ: PDLI) announces that John McLaughlin, PDL’s chief executive officer, will present at the 2018 Cantor Fitzgerald Global Healthcare Conference in New York City. The session will be webcast live and will occur on Wednesday, October 3, 2018, at 12:15pm EDT.

Providence St. Joseph Health, the nation’s third-largest health system, announces today it has been named to Forbes’ list of Best Employers for New Grads. The health system ranked No. 9 out of the top 250 companies in the United States and No. 1 out of all listed health care organizations.

The Company will release its third quarter 2018 results prior to the call.

Company Introduces Non-mydriatic Ophthalmic Camera